rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1999-5-6
|
pubmed:abstractText |
The aim of this study was to fully characterize newly developed radioactive rhenium glass microspheres in vivo by determining their biodistribution, stability, antitumor effect, and toxicity after hepatic arterial injection in a syngeneic rat hepatoma model. The dose response of the tumors to increasing amounts of radioactive 186Re and 188Re microspheres was also determined.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0360-3016
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
189-99
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10219814-Animals,
pubmed-meshheading:10219814-Drug Screening Assays, Antitumor,
pubmed-meshheading:10219814-Embolization, Therapeutic,
pubmed-meshheading:10219814-Liver Neoplasms, Experimental,
pubmed-meshheading:10219814-Male,
pubmed-meshheading:10219814-Microspheres,
pubmed-meshheading:10219814-Radioisotopes,
pubmed-meshheading:10219814-Radiopharmaceuticals,
pubmed-meshheading:10219814-Rats,
pubmed-meshheading:10219814-Rats, Sprague-Dawley,
pubmed-meshheading:10219814-Rhenium,
pubmed-meshheading:10219814-Tissue Distribution
|
pubmed:year |
1999
|
pubmed:articleTitle |
Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres.
|
pubmed:affiliation |
Department of Radiation Oncology, The Cleveland Clinic Foundation, OH 44195, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|